HOUSTON - (EMBARGOED: not for release before 3 p.m. CDT April 5, 2005)--Three University of Texas School of Public Health at Houston faculty members are co-authors of an article in the April 6 issue of The Journal of the American Medical Association. The article reports study results suggesting older, cheaper diuretics remain the drug of choice for both black and non-black patients in treating high blood pressure and reducing risk of heart disease.

The analysis by race of the "Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial" (ALLHAT), confirms earlier findings that diuretics rather than newer, more expensive drugs such as ACE inhibitors, calcium channel blockers, or beta blockers should be preferred as a first therapy for most patients.

The multi-center ALLHAT study is conducted under a National Institutes of Health contract with The University of Texas Health Science Center at Houston. Barry R. Davis, M.D., Ph.D., professor of biostatistics in the UT School of Public Health is the Principal Investigator and a co-author of the JAMA article.

"There was question whether the diuretics' success with hypertension applied by race because black patients have less success than non-black patients with the ACE inhibitors," said Davis, who also is director of the Coordinating Center for Clinical Trials at the UT School of Public Health. "However the results showed diuretics were as good or better than the newer drugs regardless of race."

The study concludes that diuretics are similar to or superior to newer drugs in lowering blood pressure, in tolerability and in preventing the major complications from high blood pressure. Across both racial subgroups, there was substantially higher risk of heart failure--37 percent--among participants taking calcium channel blockers compared with those on diuretics. When compared to ACE inhibitors, diuretics were more effective in preventing cardiovascular disease, especially heart
'"/>

Contact: Melanie Hillis
Melanie.Hillis@uth.tmc.edu
713-500-3308
University of Texas Health Science Center at Houston
5-Apr-2005

Page: 1 2
Related medicine news :

1. ALLHAT study findings for racial sub-groups show diuretics work better for high blood pressure
2. Cedars-Sinai researchers present new endocrine findings at 2 international conferences
3. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
4. ENDEAVOR III Trial reports key findings on new-generation stent
5. SLEEP 2007 to present more than 1,100 new findings and developments on sleep disorders
6. Preventive Medicine 2007 to feature research and practice findings to improve public health
7. CHPA statement regarding Monitoring the Future findings on cough medicine abuse
8. OHSU findings may improve how people with chronic heartburn, precancer of the esophagus are screened
9. Columbia scientists present research findings at AHA Scientific Sessions
10. Cincinnati Childrens researchers publish findings on potential target for leukemia treatment
11. New findings could lead to vaccine for severe malaria